Loading clinical trials...
Loading clinical trials...
Safety and Feasibility of a Shigella Sonnei 53G Controlled Human Infection Model in Kenyan Adults: a Dose Finding and Dose Verification Study
Conditions
Interventions
Shigella sonnei 53G
Ciprofloxacin 500 mg
Locations
1
Kenya
KEMRI-Wellcome Trust Research Programme
Kilifi, Kenya
Start Date
January 21, 2025
Primary Completion Date
April 30, 2026
Completion Date
August 30, 2027
Last Updated
March 13, 2025
NCT05182749
NCT05156528
NCT02797236
Lead Sponsor
University of Oxford
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions